Avenue Therapeutics Statistics
Total Valuation
ATXI has a market cap or net worth of 2.45 million. The enterprise value is -2.51 million.
| Market Cap | 2.45M |
| Enterprise Value | -2.51M |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATXI has 3.18 million shares outstanding. The number of shares has increased by 215.22% in one year.
| Current Share Class | 3.18M |
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | +215.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.71% |
| Owned by Institutions (%) | 3.15% |
| Float | 2.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.74 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.67 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.62
| Current Ratio | 2.62 |
| Quick Ratio | 2.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -191.15% and return on invested capital (ROIC) is -124.12%.
| Return on Equity (ROE) | -191.15% |
| Return on Assets (ROA) | -77.30% |
| Return on Invested Capital (ROIC) | -124.12% |
| Return on Capital Employed (ROCE) | -170.52% |
| Revenue Per Employee | 702,000 |
| Profits Per Employee | -1.87M |
| Employee Count | 2 |
| Asset Turnover | 0.44 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.10% in the last 52 weeks. The beta is -0.31, so ATXI's price volatility has been lower than the market average.
| Beta (5Y) | -0.31 |
| 52-Week Price Change | -59.10% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 0.59 |
| Relative Strength Index (RSI) | 49.18 |
| Average Volume (20 Days) | 3,084 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.24 |
Income Statement
In the last 12 months, ATXI had revenue of 1.40 million and -3.74 million in losses. Loss per share was -1.33.
| Revenue | 1.40M |
| Gross Profit | 1.40M |
| Operating Income | -3.93M |
| Pretax Income | -3.78M |
| Net Income | -3.74M |
| EBITDA | n/a |
| EBIT | -3.93M |
| Loss Per Share | -1.33 |
Balance Sheet
The company has 3.71 million in cash and n/a in debt, giving a net cash position of 3.71 million or 1.17 per share.
| Cash & Cash Equivalents | 3.71M |
| Total Debt | n/a |
| Net Cash | 3.71M |
| Net Cash Per Share | 1.17 |
| Equity (Book Value) | 2.30M |
| Book Value Per Share | 1.12 |
| Working Capital | 2.30M |
Cash Flow
| Operating Cash Flow | -1.74M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -279.70% and -266.67%.
| Gross Margin | 100.00% |
| Operating Margin | -279.70% |
| Pretax Margin | -269.23% |
| Profit Margin | -266.67% |
| EBITDA Margin | n/a |
| EBIT Margin | -279.70% |
| FCF Margin | n/a |
Dividends & Yields
ATXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -215.22% |
| Shareholder Yield | -215.22% |
| Earnings Yield | -152.93% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.0133333.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0133333 |
Scores
ATXI has an Altman Z-Score of -40.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -40.83 |
| Piotroski F-Score | 1 |